Brief: Tnf Pharmaceuticals Announces Trial To Explore Effects Of Lead Candidate In Sarcopenia/Frailty Induced By Glp-1 Weight Loss Drugs
19/12/2024 14:18
Dec 19 (Reuters) - TNF Pharmaceuticals Inc TNFA.O :
* TNF PHARMACEUTICALS ANNOUNCES TRIAL TO EXPLORE EFFECTS OF
LEAD
CANDIDATE IN SARCOPENIA/FRAILTY INDUCED BY GLP-1 WEIGHT LOSS
DRUGS
* FULLY FUNDED STUDY TO EVALUATE WEGOVY AND OZEMPIC PATIENTS
AT
RISK FOR INCREASED INFLAMMATION ASSOCIATED WITH SARCOPENIC
MUSCLE DETERIORATION
* ENTERS COLLABORATIVE AGREEMENT WITH RENOVA HEALTH
Source text: ID:nBw9jKjzfa
Further company coverage: TNFA.O
((Reuters.Briefs@thomsonreuters.com;))